Interventions for idiopathic intracranial hypertension
Related Experiment Video
Updated: Aug 16, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
1Department of Neurology, Canberra Hospital, P.O. Box 11, Woden, Australia, 2606. Christian.Lueck@act.gov.au
Insights
No randomized controlled trials were found for idiopathic intracranial hypertension treatments. More research is needed to determine effective and safe management strategies for this condition.
Area of Science:
- Neurology
- Ophthalmology
Background:
- Idiopathic intracranial hypertension (IIH) affects 1-3 per 100,000 people globally, predominantly obese young women.
- IIH poses a significant risk to vision and causes morbidity, primarily severe headaches.
- Current treatments range from conservative (diuretics) to invasive (surgery).
Purpose of the Study:
- To review the effects of various treatments for idiopathic intracranial hypertension.
- To develop an evidence-based treatment strategy for IIH.
Main Methods:
- Searched Cochrane CENTRAL, MEDLINE, and EMBASE databases (up to January 2005).
- Included only randomized controlled trials comparing IIH treatments against placebo or other interventions.
- Two authors independently assessed search results; discrepancies were resolved by discussion.
Main Results:
- No randomized controlled trials met the inclusion criteria for the review.
- Consequently, no quality assessment or meta-analysis was performed.
Conclusions:
- Insufficient evidence exists to establish an evidence-based management strategy for IIH.
- Further properly designed trials are essential to identify beneficial and potentially harmful treatments for IIH.
Background:
Idiopathic intracranial hypertension occurs throughout the world with an estimated incidence of one to three per 100,000 population per year. It occurs most commonly in obese young women but the cause is unknown. It presents a significant threat to sight and is associated with severe morbidity, in the form of headaches in most cases. Several different treatments have been proposed ranging from relatively conservative measures such as diuretic therapy to more invasive treatments such as optic nerve sheath fenestration, stenting of cerebral venous sinuses, or lumbo-peritoneal shunting.
Objectives:
The objective of this review was to assess the effects of various forms of treatment for idiopathic intracranial hypertension with a view to producing an evidence-based treatment strategy.
Search Strategy:
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), which contains the Cochrane Eyes and Vision Group Trials Register, on The Cochrane Library (Issue 4, 2004), MEDLINE (1966 to January 2005) and EMBASE (1980 to January 2005).
Selection Criteria:
We included only randomised controlled trials in which any intervention used to treat idiopathic intracranial hypertension had been compared to placebo or to another form of treatment in people with a clinical diagnosis of idiopathic intracranial hypertension.
Data Collection And Analysis:
Both authors independently assessed the search results for trials to be included in the review. Discrepancies were resolved by discussion. Since no trials met our inclusion criteria, no assessment of quality or meta-analysis was undertaken.
Main Results:
No randomised controlled trials were found that met the inclusion criteria.
Authors' Conclusions:
There is insufficient information to generate an evidence-based management strategy for idiopathic intracranial hypertension. There is inadequate information regarding which treatments are truly beneficial and which are potentially harmful. Properly designed and executed trials are needed.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Cerebral Edema l: Introduction
Hypertension V: Nursing Management